Literature DB >> 16171612

Evaluation of the microcirculation in vascular disease.

Christopher J Abularrage1, Anton N Sidawy, Gilbert Aidinian, Niten Singh, Jonathan M Weiswasser, Subodh Arora.   

Abstract

Insufficient blood flow through end-resistance arteries leads to symptoms associated with peripheral vascular disease. This may be caused in part by poor macrocirculatory inflow or impaired microcirculatory function. Dysfunction of the microcirculation occurs in a similar fashion in multiple tissue beds long before the onset of atherosclerotic symptoms. Impaired microcirculatory vasodilatation has been shown to occur in certain disease states including peripheral vascular disease, diabetes mellitus, hypercholesterolemia, hypertension, chronic renal failure, abdominal aortic aneurysmal disease, and venous insufficiency, as well as in menopause, advanced age, and obesity. Microcirculatory structure and function can be evaluated with transcutaneous oxygen, pulp skin flow, iontophoresis, and capillaroscopy. We discuss the importance of the microcirculation, investigative methods for evaluating its function, and clinical applications and review the literature of the microcirculation in these different states.

Entities:  

Mesh:

Year:  2005        PMID: 16171612     DOI: 10.1016/j.jvs.2005.05.019

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  63 in total

1.  Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans.

Authors:  Caroline J Smith; Lakshmi Santhanam; Rebecca S Bruning; Anna Stanhewicz; Dan E Berkowitz; Lacy A Holowatz
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

Review 2.  Thermal provocation to evaluate microvascular reactivity in human skin.

Authors:  Christopher T Minson
Journal:  J Appl Physiol (1985)       Date:  2010-05-27

3.  Sensory nerve-mediated and nitric oxide-dependent cutaneous vasodilation in normotensive and prehypertensive non-Hispanic blacks and whites.

Authors:  Brett J Wong; Casey G Turner; James T Miller; Demetria C Walker; Yesser Sebeh; Matthew J Hayat; Jeffrey S Otis; Arshed A Quyyumi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-19       Impact factor: 4.733

4.  Seven consecutive days of remote ischaemic preconditioning improves cutaneous vasodilatory capacity in young adults.

Authors:  James A Lang; Jahyun Kim; Warren D Franke; Lauro C Vianna
Journal:  J Physiol       Date:  2018-12-17       Impact factor: 5.182

5.  Human cutaneous microvascular ageing: potential insights into underlying physiological mechanisms of endothelial function and dysfunction.

Authors:  Lacy A Holowatz
Journal:  J Physiol       Date:  2008-07-15       Impact factor: 5.182

6.  Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J Dupont; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

7.  NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J DuPont; Meghan G Ramick; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-23

8.  In vivo photoacoustic microscopy of human cutaneous microvasculature and a nevus.

Authors:  Christopher P Favazza; Omar Jassim; Lynn A Cornelius; Lihong V Wang
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

9.  Blood pressure normalization via pharmacotherapy improves cutaneous microvascular function through NO-dependent and NO-independent mechanisms.

Authors:  Daniel H Craighead; Caroline J Smith; Lacy M Alexander
Journal:  Microcirculation       Date:  2017-10       Impact factor: 2.628

10.  Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress.

Authors:  Jody L Greaney; Jennifer J DuPont; Shannon L Lennon-Edwards; Paul W Sanders; David G Edwards; William B Farquhar
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.